Holen Sie sich die Stockscreener-App
148.12
1.24%
1.82
Handel nachbörslich:
147.70
-0.42
-0.28%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$146.30
Offen:
$147.63
24-Stunden-Volumen:
3.42M
Relative Volume:
1.57
Marktkapitalisierung:
$35.35B
Einnahmen:
$222.29B
Nettoeinkommen (Verlust:
$1.56B
KGV:
23.11
EPS:
6.41
Netto-Cashflow:
$2.44B
1W Leistung:
-5.42%
1M Leistung:
-7.98%
6M Leistung:
+16.83%
1J Leistung:
+44.39%
1-Tages-Spanne:
$145.47
$148.76
1-Wochen-Bereich:
$137.75
$159.41
52-Wochen-Spanne:
$105.01
$168.44
Cardinal Health Inc Stock (CAH) Company Profile
Firmenname
Cardinal Health Inc
Sektor
Branche
Telefon
(614) 757-3033
Adresse
7000 CARDINAL PLACE, DUBLIN, OH
Vergleichen Sie CAH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
148.12 | 37.63B | 222.29B | 1.56B | 2.44B | 6.41 |
|
MCK
Mckesson Corporation
|
663.17 | 83.68B | 377.60B | 3.16B | 5.67B | 25.08 |
|
COR
Cencora Inc
|
291.04 | 56.36B | 316.65B | 1.90B | 1.14B | 9.72 |
|
HSIC
Henry Schein Inc
|
68.99 | 8.02B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.77 | 689.96M | 2.22M | -5.63M | -1.68M | -0.24 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | Hochstufung | Jefferies | Hold → Buy |
| 2025-01-08 | Hochstufung | TD Cowen | Hold → Buy |
| 2025-01-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-12-13 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | Fortgesetzt | Mizuho | Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-09 | Hochstufung | Argus | Hold → Buy |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Underweight |
| 2023-07-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-03-31 | Eingeleitet | Citigroup | Neutral |
| 2023-02-03 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-05-26 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-05-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-04-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-08-06 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-08-05 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-05-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-09-25 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-07-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-05-15 | Hochstufung | UBS | Neutral → Buy |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-03-20 | Hochstufung | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-27 | Herabstufung | Argus | Buy → Hold |
| 2019-08-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-04-18 | Eingeleitet | Guggenheim | Neutral |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2018-11-16 | Herabstufung | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | Hochstufung | Argus | Hold → Buy |
| 2018-03-08 | Eingeleitet | Barclays | Equal Weight |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Underperform |
| 2018-01-05 | Eingeleitet | Evercore ISI | In-line |
Alle ansehen
Cardinal Health Inc Aktie (CAH) Neueste Nachrichten
Cardinal Health Starts High-Grade Bond Sale to Fund Solaris Deal - Bloomberg.com
Cardinal Health (CAH) Falls on Dismal Revenue Performance - MSN
Deutsche Bank Adjusts Cardinal Health Price Target to $176 From $163 - MarketScreener
Cardinal Health Offers $1 Billion of Bonds for Solaris Deal - Yahoo Finance
Market Tremors: Cava Group, CoreWeave, Kroger, and Cardinal Health Inc. Face Significant Declines - FinancialContent
Cardinal Health starts high-grade bond sale to fund Solaris deal - Crain's Cleveland Business
Cardinal Health to Sell Bonds to Help Fund $1.9 Billion Solaris Health Acquisition - MarketScreener
Cardinal Health: $1.9 Billion Deal For Solaris Health - Pulse 2.0
Form 424B3 CARDINAL HEALTH INC - StreetInsider
Cardinal Health, Inc. (NYSE:CAH) Q4 2025 Earnings Call Transcript - Insider Monkey
Citigroup Adjusts Price Target on Cardinal Health to $165 From $170, Maintains Neutral Rating - MarketScreener
Baird Adjusts Price Target on Cardinal Health to $203 From $197, Maintains Outperform Rating - MarketScreener
Cardinal Health to acquire Solaris Health for USD 1.9 billion in cash - Medical Buyer
Cardinal Health Inc (CAH) Q4 2025 Earnings Call Highlights: Strong Financial Performance Amid Contract Challenges - GuruFocus
Cardinal Health 2025 Q4 Earnings Strong Performance as Net Income Surges 4.3% - AInvest
Cardinal Health Reports Strong Q4 and FY 2025 Results - TipRanks
Decoding Cardinal Health Inc (CAH): A Strategic SWOT Insight - GuruFocus
Cardinal Health (CAH) Tops Q4 Earnings Estimates - MSN
Cardinal Health Sells Bonds To Back Solaris Health Deal - Finimize
Cardinal Health to buy Solaris Health for $1.9 billion, posts weak results - ET HealthWorld
Cardinal Health’s Strong Performance and Strategic Initiatives Justify Buy Rating - TipRanks
Cardinal Health to Extend Reach by Acquiring Solaris Health - PYMNTS.com
Why Cardinal Health Stock Was Tumbling on Tuesday - AOL.com
Lee Equity Partners exits Solaris Health in $1.9B sale to Cardinal Health - PitchBook
New Customers, Solid Prescription Trend, and Growing Specialties Support Cardinal's Long-Term Growth - Morningstar
Cardinal Health Reports Flat 4Q Revenue, Higher Profit and a $1.9B Acquisition - Modern Distribution Management
Despite Profit Surge, Cardinal Health Shares Tumble on Revenue Shortfall - FinancialContent
Ohio giant Cardinal Health makes $1.9 billion urology deal - Crain's Cleveland Business
JPMorgan Adjusts Price Target on Cardinal Health to $178 From $175 - MarketScreener
Cardinal Health Q4 Earnings Beat Estimates, Revenue Hits $60.16BNews and Statistics - IndexBox
Cardinal Health Q4 2025 Earnings Call Transcript - MarketBeat
Cardinal Health, Inc. ($CAH) Stock: Shares Drop as Revenue Misses Despite Raised Outlook and $1.9B Solaris Deal - CoinCentral
Cardinal Health price target lowered to $186 from $188 at Leerink - TipRanks
Evercore ISI Cuts Price Target on Cardinal Health to $190 From $200 - MarketScreener
Leerink Partners Adjusts Price Target on Cardinal Health to $186 From $188 - MarketScreener
Mixed Fortunes: Chipotle Sizzles on Upgrades, Cardinal Health Stumbles Despite Profit Beat - FinancialContent
Cardinal Health expands urology focus with $1.9bn Solaris Health deal - Yahoo Finance
Cardinal Health (CAH) Reports US$1,561 Million Net Income With Strong Earnings Per Share Growth - simplywall.st
Cardinal Health to Acquire Solaris in $1.9B Deal - USA Herald
Sea, Cardinal Health, Circle, and On Holding: Here are the stocks moving this morning - MSN
Cardinal Health To Provide $1.9B To Specialty Alliance Division To Enable Solaris Health Acquisition: More Details Inside - Stocktwits
Cardinal Health commits $1.9 billion cash for deal to buy Solaris Health - kdal610.com
Zacks Industry Outlook Highlights McKesson, Cardinal Health, West Pharmaceutical Services and The Cooper Companies - The Globe and Mail
Cardinal Health Reports Q4 2025 Financial Results - TipRanks
3 Firms Advise As Cardinal Health Makes $1.9B Urology Push - Law360
Cardinal Health Boosts Specialty Presence With Solaris Health Acquisition, Lifts Profit Outlook - AOL.com
Intel CEO meets with Trump, Cardinal Health to acquire Solaris: Morning Buzz - TipRanks
Cardinal Health profit nearly doubles in FY25 despite flat salesColumbus Business First - The Business Journals
Transcript : Cardinal Health, Inc., Q4 2025 Earnings Call, Aug 12, 2025 - MarketScreener
Top Stock Movers Now: Hanesbrands, On Holding, Cardinal Health, and More - Investopedia
Contradictions Unveiled: Analyzing Cardinal Health's Q4 2025 Earnings Call Insights on Tariffs and Pharma Growth - AInvest
Finanzdaten der Cardinal Health Inc-Aktie (CAH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.65%
4.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):